Kalif Eliyahu Sharon 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Jan 29, 2026

AI-generated summary of this filing

Updated Jan 29, 2026

TEVA CFO Kalif E. Sharon Receives 141,478 RSU Award

What Happened

Kalif E. Sharon, Chief Financial Officer of Teva Pharmaceutical Industries (TEVA), was granted 141,478 restricted share units (RSUs) on January 27, 2026. The Form 4 lists the transaction as an award/acquisition (code A) and reports acquisition price as $0.00 (derivative award).

Key Details

Transaction date: 2026-01-27; Form 4 filed: 2026-01-29 (timely filing).
Shares/units granted: 141,478 restricted share units; Form reports $0.00 acquisition price (compensation award, not an open-market purchase).
Vesting/settlement: These RSUs are contingent rights that, at settlement, convert to one ordinary share each or cash at the committee’s option (footnote). They were issued upon satisfaction of performance criteria and remain subject to time-based vesting, scheduled to vest on March 3, 2026.
Ordinary shares may be represented by ADRs (American Depositary Shares) (footnote).
Shares owned after transaction: not specified in the provided filing.

Context

This is a compensation grant (derivative award), not a purchase or sale; such awards are routine executive compensation and do not by themselves signal a buying or selling choice by the insider. The RSUs reflect performance criteria having been met but still carry a time-based vesting condition before settlement.

Form 4

Period: 2026-01-27

EVP, Chief Financial Officer

Transactions

Award
Restricted Share Units
[F1][F2][F3]
2026-01-27+141,478→ 141,478 total
→ Ordinary Shares (141,478 underlying)

Footnotes (3)

[F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
[F2]Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026.
[F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Signature

/s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif|2026-01-29

1 file